Due to the iron dependence of ferroptosis, treatment with DAC has been shown to reduce the antioxidant activity of GPX4 in MDS cells, leading to increased ROS release and the evolution of AML through ferroptosis activation [111]. This evidence concerns the gene GPX4 and acute myeloid leukemia.